VESTA Trademark

Trademark Overview


On Thursday, February 3, 2022, a trademark application was filed for VESTA with the United States Patent and Trademark Office. The USPTO has given the VESTA trademark a serial number of 97251620. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, September 9, 2024. This trademark is owned by Vesta Therapeutics, INC.. The VESTA trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services for others in the field of clinical grade media for therapy programs

Biological preparations for the treatment cancer and diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Pharmaceutical preparations for the treatment of cancer and for treatment of diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Cell growth media for growing cells for medical or clinical use

Biological tissue, namely, human or animal tissue and blood for use in scientific and medical research; Cell growth media for growing cells for scientific and research use

Research and development in the biotechnology field
vesta

General Information


Serial Number97251620
Word MarkVESTA
Filing DateThursday, February 3, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesManufacturing services for others in the field of clinical grade media for therapy programs
Goods and ServicesBiological preparations for the treatment cancer and diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Pharmaceutical preparations for the treatment of cancer and for treatment of diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Cell growth media for growing cells for medical or clinical use
Goods and ServicesBiological tissue, namely, human or animal tissue and blood for use in scientific and medical research; Cell growth media for growing cells for scientific and research use
Goods and ServicesResearch and development in the biotechnology field

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVesta Therapeutics, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHanover, MD 21076

Party NameVesta Therapeutics, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHanover, MD 21076

Trademark Events


Event DateEvent Description
Tuesday, February 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 16, 2022ASSIGNED TO EXAMINER
Tuesday, November 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2022NON-FINAL ACTION E-MAILED
Monday, May 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 15, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 15, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 15, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 6, 2024SOU EXTENSION 1 FILED
Wednesday, March 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU EXTENSION 2 FILED
Monday, September 9, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 6, 2024SOU EXTENSION 1 GRANTED